Literature DB >> 24554489

Hyperuricemia and cardiovascular risk.

Davide Grassi1, Giovambattista Desideri, Anna Vittoria Di Giacomantonio, Paolo Di Giosia, Claudio Ferri.   

Abstract

There is an increasing prevalence of gout and hyperuricemia worldwide. Gout confers a significant individual and social burden and is increasingly recognized as a prevalent chronic disease state requiring appropriate long-term management. Gout and hyperuricemia appear to be independent risk factors for incident hypertension, renal disease and cardiovascular disease. Multiple epidemiologic studies confirm an association between hyperuricemia and "cardiometabolic disease". We review the evidence stating the relationship between hyperuricemia and the development of comorbid conditions contributing to cardiovascular risk and disease.

Entities:  

Mesh:

Year:  2014        PMID: 24554489     DOI: 10.1007/s40292-014-0046-3

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  36 in total

1.  Uric acid and diet--insights into the epidemic of cardiovascular disease.

Authors:  Richard J Johnson; Bruce A Rideout
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

2.  Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome.

Authors:  Tae Woo Yoo; Ki Chul Sung; Hun Sub Shin; Byung Jin Kim; Bum Soo Kim; Jin Ho Kang; Man Ho Lee; Jung Ro Park; Hyang Kim; Eun Jung Rhee; Won Young Lee; Sun Woo Kim; Seung Ho Ryu; Dong Geuk Keum
Journal:  Circ J       Date:  2005-08       Impact factor: 2.993

3.  Ischemia-reperfusion in humans. Appearance of xanthine oxidase activity.

Authors:  H P Friedl; D J Smith; G O Till; P D Thomson; D S Louis; P A Ward
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

4.  Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study.

Authors:  B F Culleton; M G Larson; W B Kannel; D Levy
Journal:  Ann Intern Med       Date:  1999-07-06       Impact factor: 25.391

Review 5.  Insulin: new roles for an ancient hormone.

Authors:  E Ferrannini; A Q Galvan; A Gastaldelli; S Camastra; A M Sironi; E Toschi; S Baldi; S Frascerra; F Monzani; A Antonelli; M Nannipieri; A Mari; G Seghieri; A Natali
Journal:  Eur J Clin Invest       Date:  1999-10       Impact factor: 4.686

Review 6.  Gout and hyperuricemia.

Authors:  Robert L Wortmann
Journal:  Curr Opin Rheumatol       Date:  2002-05       Impact factor: 5.006

7.  Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study.

Authors:  P Verdecchia; G Schillaci; G Reboldi; F Santeusanio; C Porcellati; P Brunetti
Journal:  Hypertension       Date:  2000-12       Impact factor: 10.190

Review 8.  Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.

Authors:  Seo Young Kim; James P Guevara; Kyoung Mi Kim; Hyon K Choi; Daniel F Heitjan; Daniel A Albert
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-02       Impact factor: 4.794

9.  Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome.

Authors:  J P Gonçalves; A Oliveira; M Severo; A C Santos; C Lopes
Journal:  Endocrine       Date:  2012-02-21       Impact factor: 3.633

10.  Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study.

Authors:  Arrigo F G Cicero; Paolo Salvi; Sergio D'Addato; Martina Rosticci; Claudio Borghi
Journal:  J Hypertens       Date:  2014-01       Impact factor: 4.844

View more
  13 in total

1.  Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study.

Authors:  Giovambattista Desideri; Agostino Virdis; Edoardo Casiglia; Claudio Borghi
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-02-09

Review 2.  Metabolic syndrome in hypertensive patients: An unholy alliance.

Authors:  Giuseppe Mulè; Ilenia Calcaterra; Emilio Nardi; Giovanni Cerasola; Santina Cottone
Journal:  World J Cardiol       Date:  2014-09-26

3.  Association of serum uromodulin with mortality and cardiovascular disease in the elderly-the Cardiovascular Health Study.

Authors:  Dominik Steubl; Petra Buzkova; Pranav S Garimella; Joachim H Ix; Prasad Devarajan; Michael R Bennett; Paulo H M Chaves; Michael G Shlipak; Nisha Bansal; Mark J Sarnak
Journal:  Nephrol Dial Transplant       Date:  2020-08-01       Impact factor: 5.992

Review 4.  Therapeutic approaches to chronic hyperuricemia and gout.

Authors:  Davide Grassi; Roberto Pontremoli; Raffaella Bocale; Claudio Ferri; Giovambattista Desideri
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-04-03

5.  Xanthine oxidase inhibitors in elderly patients with heart failure: useful or useless?

Authors:  Vivianne Presta; Barbara Citoni; Giuliano Tocci
Journal:  Intern Emerg Med       Date:  2019-05-13       Impact factor: 3.397

6.  Major Cardiovascular Events in Patients with Gout and Associated Cardiovascular Disease or Heart Failure and Chronic Kidney Disease Initiating a Xanthine Oxidase Inhibitor.

Authors:  JoAnne Foody; Robin S Turpin; Beni A Tidwell; Debra Lawrence; Kathy L Schulman
Journal:  Am Health Drug Benefits       Date:  2017-11

7.  Factors Associated with Benign Paroxysmal Positional Vertigo: A Chinese Case-Control Study.

Authors:  Junliang Yuan; Jinsheng Dai; William A Li; Wenli Hu
Journal:  Med Sci Monit       Date:  2017-08-11

Review 8.  Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis.

Authors:  Rui Liu; Cheng Han; Di Wu; Xinghai Xia; Jianqiu Gu; Haixia Guan; Zhongyan Shan; Weiping Teng
Journal:  Biomed Res Int       Date:  2015-11-10       Impact factor: 3.411

9.  The association between serum uric acid and blood pressure in different age groups in a healthy Chinese cohort.

Authors:  Wenjuan Cheng; Shiling Wen; Yutang Wang; Zhiping Qian; Yuyao Tan; Hongying Li; Yueli Hou; Haiyang Hu; Jonathan Golledge; Guang Yang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

10.  Xanthine Oxidase Inhibition by Febuxostat in Macrophages Suppresses Angiotensin II-Induced Aortic Fibrosis.

Authors:  Masateru Kondo; Masaki Imanishi; Keijo Fukushima; Raiki Ikuto; Yoichi Murai; Yuya Horinouchi; Yuki Izawa-Ishizawa; Mitsuhiro Goda; Yoshito Zamami; Kenshi Takechi; Masayuki Chuma; Yasumasa Ikeda; Hiromichi Fujino; Koichiro Tsuchiya; Keisuke Ishizawa
Journal:  Am J Hypertens       Date:  2019-02-12       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.